Financial Synergies Wealth Advisors, Inc. Royalty Pharma PLC Transaction History

Financial Synergies Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$27.46 - $31.33 $411 - $469	15 Added 41.67%	51 $1.55 Million
Q4 2023 Apr 04, 2024	SELL	$26.21 - $29.22 $393 - $438	-15 Reduced 29.41%	36 $1.42 Million
Q3 2023 Apr 04, 2024	BUY	$26.26 - $31.38 $656 - $784	25 Added 96.15%	51 $1.39 Million
Q2 2023 Apr 04, 2024	SELL	$29.6 - $36.56 $562 - $694	-19 Reduced 42.22%	26 $800,000
Q1 2023 Apr 04, 2024	BUY	$32.77 - $39.4 $294 - $354	9 Added 25.0%	45 $1.62 Million
Q4 2022 Apr 04, 2024	BUY	$39.17 - $44.04 $626 - $704	16 Added 80.0%	36 $1.42 Million
Q2 2022 Apr 04, 2024	BUY	$37.53 - $44.22 $750 - $884	20 New	20 $841,000

396

291M

305K

138K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Financial Synergies Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Synergies Wealth Advisors, Inc. with notifications on news.